$1.9 Billion is the total value of QVT Financial LP's 52 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GDS | Exit | GDS HLDGS LTDsponsored ads | $0 | – | -17,700 | -100.0% | -0.02% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -98,644 | -100.0% | -0.03% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INCput | $0 | – | -505,000 | -100.0% | -0.04% | – |
| BIDU | Exit | BAIDU INCspon adr rep a | $0 | – | -5,200 | -100.0% | -0.04% | – |
| ACMR | Exit | ACM RESH INC | $0 | – | -70,119 | -100.0% | -0.06% | – |
| FRG | Exit | FRANCHISE GROUP INC | $0 | – | -130,120 | -100.0% | -0.22% | – |
| LBTYA | Exit | LIBERTY GLOBAL PLC | $0 | – | -242,800 | -100.0% | -0.26% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -3,525,000 | -100.0% | -0.29% | – |
| NIO | Exit | NIO INCcall | $0 | – | -300,000 | -100.0% | -0.33% | – |
| Exit | H WORLD GROUP LTDnote 0.375%11/0 | $0 | – | -4,780,000 | -100.0% | -0.33% | – | |
| NE | Exit | NOBLE CORP NEW | $0 | – | -257,294 | -100.0% | -0.53% | – |
| LILAK | Exit | LIBERTY LATIN AMERICA LTD | $0 | – | -1,749,467 | -100.0% | -0.75% | – |
| Exit | CLOVIS ONCOLOGY INCnote 4.500% 8/0 | $0 | – | -21,000,000 | -100.0% | -0.89% | – | |
| Exit | MICROSTRATEGY INCnote 0.750%12/1 | $0 | – | -20,000,000 | -100.0% | -1.07% | – | |
| Exit | CARNIVAL CORPnote 5.750% 4/0 | $0 | – | -16,000,000 | -100.0% | -1.17% | – | |
| ILMN | Exit | ILLUMINA INCcall | $0 | – | -146,200 | -100.0% | -1.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
| 13F-HR | 2023-05-15 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.